SCHEMBL30196071

SCHEMBL30196071

COCOc1cc2c(cc1B1OC(C)(C)C(C)(C)O1)OCN2C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25168054 0.80 CYP3A4 (0.35) —
SCHEMBL17423953 0.76 JAK2 (0.36) —
SCHEMBL31207146 0.74 RXFP1 (0.41) —
SCHEMBL31753982 0.72 EGFR (0.36) —
SCHEMBL19087000 0.71 CSF1R (0.34) —
SCHEMBL22320285 0.71 ACHE (0.33) —
SCHEMBL25064941 0.71 P2RX7 (0.33) —
SCHEMBL25064944 0.71 P2RX7 (0.33) —
SCHEMBL25065570 0.71 P2RX7 (0.33) —
SCHEMBL28544224 0.71 CA1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230020922-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-19 — — US disclosed
Send feedback